Yoshiaki Abe
Impact in
- Molecular Medicine top 2%
- Curcumin's Biomedical Applications
- Genetics top 10%
- Glioma Diagnosis and Treatment
Papers in
- Hematology 20
- Multiple Myeloma Research and Treatments 18
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 7
- Protein Degradation and Inhibitors 4
- Co-authors
- Takashi Horie (2 shared papers)Shu Hashimoto (2 shared papers)Kosei Matsue (33 shared papers)Kentaro Narita (32 shared papers)Masami Takeuchi (32 shared papers)Hiroki Kobayashi (27 shared papers)Akihiro Kitadate (25 shared papers)Daisuke Miura (15 shared papers)
- Journals
- Blood (12 papers)International Journal of Hematology (4 papers)Oncotarget (3 papers)Infection and Immunity (2 papers)Anticancer Research (2 papers)
- Partner nations
- JapanUnited StatesNigeria
In The Last Decade
Yoshiaki Abe
68 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 97
- Molecular Medicine 230
- Genetics 142
- Hematology 138
- Pathology and Forensic Medicine 189
- Neurology 158
Countries citing papers authored by Yoshiaki Abe
This map shows the geographic impact of Yoshiaki Abe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshiaki Abe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshiaki Abe more than expected).
Fields of papers citing papers by Yoshiaki Abe
This network shows the impact of papers produced by Yoshiaki Abe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshiaki Abe. The network helps show where Yoshiaki Abe may publish in the future.
Co-authors
The 25 scholars most cited alongside Yoshiaki Abe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 363 | |
| 2 | 2012 | 70 | |
| 3 | 2002 | 57 | |
| 4 | 2019 | 47 | |
| 5 | 2019 | 41 | |
| 6 | 2019 | 32 | |
| 7 | 1998 | 32 | |
| 8 | 2021 | 31 | |
| 9 | 2020 | 30 | |
| 10 | 2017 | 30 | |
| 11 | 2018 | 24 | |
| 12 | 1990 | 22 | |
| 13 | 2019 | 19 | |
| 14 | 1977 | 16 | |
| 15 | Polymorphism in the Ialpha1 germ-line transcript regulatory region and IgA productivity in patients with IgA nephropathy. | 1998 | 15 |
| 16 | 1995 | 14 | |
| 17 | 2018 | 14 | |
| 18 | 2018 | 13 | |
| 19 | 2005 | 12 | |
| 20 | 2019 | 11 |
About Yoshiaki Abe
Yoshiaki Abe is a scholar working on Hematology, Molecular Biology, Pathology and Forensic Medicine, Oncology and Neurology, having authored 74 papers that have together received 1.1k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (18 papers), Lymphoma Diagnosis and Treatment (16 papers), CNS Lymphoma Diagnosis and Treatment (10 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (7 papers), Hematological disorders and diagnostics (6 papers), Protein Degradation and Inhibitors (4 papers), Glioma Diagnosis and Treatment (4 papers) and Peptidase Inhibition and Analysis (4 papers). The work is most often cited by research in Molecular Medicine (230 citations), Genetics (142 citations), Hematology (138 citations), Pathology and Forensic Medicine (189 citations) and Neurology (158 citations). Yoshiaki Abe has collaborated with scholars based in Japan, United States and Nigeria. Frequent co-authors include Takashi Horie, Shu Hashimoto, Kosei Matsue, Kentaro Narita, Masami Takeuchi, Hiroki Kobayashi, Akihiro Kitadate, Daisuke Miura, Kengo Takeuchi and Toshihiro O’uchi. Their work appears in journals such as Blood, International Journal of Hematology, Oncotarget, Infection and Immunity and Anticancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.